Evidence map›Paper›PMID 38555552›Full record

ArticleJournal of thrombosis and thrombolysis2024

Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome.

Yee-Jen Wu, Chien-Chih Wu, Hsin-Yi Huang, Chi-Yun Wu, Ching-Chang Huang, Chi-Chuan Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yee-Jen WuDepartment of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
Chien-Chih WuDepartment of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
Hsin-Yi HuangSchool of Pharmacy, College of Medicine, National Taiwan University, Room 203, No. 33 Linsen S. Rd., Zhongzheng Dist, Taipei, 10050, Taiwan.
Chi-Yun WuDepartment of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
Ching-Chang HuangDivision of Cardiology, Department of Internal Medicine and Cardiovascular Center, National Taiwan University Hospital, Taipei, Taiwan.
Chi-Chuan WangDepartment of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan. chicwang@ntu.edu.tw.ORCID http://orcid.org/0000-0002-4597-4859

Funding

National Science and Technology Council MOST 111-2636-B-002-019National Taiwan University Hospital NTUH 112-S0100
6 · The paper itself

Abstract

Low-dose prasugrel demonstrated a similar effectiveness profile to clopidogrel in East Asian ACS patients, but its comparison with another new-generation potent P2Y

Indexed as

Acute Coronary SyndromePrasugrel HydrochlorideTicagrelorAspirinEast Asian PeopleGastrointestinal HemorrhageHumansIntracranial HemorrhagesPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsRetrospective StudiesTreatment OutcomeAspirinPlatelet Aggregation InhibitorsPrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsTicagrelorDual antiplatelet therapyEast Asian populationIschemic eventsLow-dose prasugrelMyocardial infarctionPotent P2Y12 inhibitors

Identifiers

PMID38555552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.